ISPOR’s Top 10 HEOR Trends for 2024-2025

By HEOR Staff Writer

January 12, 2024

Introduction: The International Society for Health Economics and Outcomes Research (ISPOR) recently released its biennial report detailing the
Pharmaceutical Pricing and Reimbursement in Latin America
A Closer Look at Access to Essential Medicines in South Sudan
NICE’s Preparations for Evaluating New Alzheimer’s Treatments
The Cost-Effectiveness of Efgartigimod Alfa (Vyvgart) in the Treatment of Mya...
Pioneering Treatments for Paroxysmal Nocturnal Hemoglobinuria
Navigating the Complexities of Generics and Biosimilars in Portugal
Unravelling the Impact of the 340B Program on US Healthcare
High-Cost Medicines in Thailand: A Global Perspective and Policy Recommendations
Inflation Reduction Act: A Game Changer for Cardiovascular Therapies Access
Patent Exclusivities and High Costs: The Challenge of Generic Competition for...
Transforming Medical Technology: The Launch of the Innovative Devices Access ...
Medicines New Zealand Unveils 2022 Transfer of Value Reports to Enhance Trans...